Search
4D Molecular Therapeutics Inc
FDMTAdd to Watchlist
14.710USD
-0.290-1.93%
Close 09-23 16:00（ET）
769.04MMarket Cap
LossP/E TTM
After-hours 16:30 (ET)14.430USD-0.295-2.00%
After-hours 16:30 (ET)4D Molecular Therapeutics Inc (FDMT) Company Valuation
2026Q3
2026Q2
2026Q1
2025Q4
2025Q3
2025Q2
2025Q1
2024Q4
2024Q3
2024Q2
2024Q1
2023Q4
Price to earnings ratio
-5.84
-5.18
-3.85
-2.00
-2.46
-1.05
-1.01
-1.87
-3.79
-8.90
-12.36
-7.64
Price to sales ratio
10.37
9.20
6.33
3491.24
14672.11
6263.93
7801.96
8119.82
30124.64
43.30
58.19
33.59
Price to cash flow ratio
-5.88
-5.21
-4.00
-2.05
-2.55
-1.09
-1.06
-1.95
-3.74
-8.98
-12.68
-8.18
Price to book ratio
1.74
1.54
1.06
0.95
0.96
0.41
0.32
0.50
1.02
1.79
4.46
2.63
Price to earnings ratio
Relevant data have not been disclosed by the company yet.
Price to book ratio
Relevant data have not been disclosed by the company yet.
Price to sales ratio
Relevant data have not been disclosed by the company yet.
Price to cash flow ratio
Relevant data have not been disclosed by the company yet.